Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Financial Information

Financial Information

Here you will find a summary of Spectrum Pharmaceuticals, Inc.'s latest financial information.

Latest Earnings Release and 10-Q Date Filed Format Size  
First Quarter Financial Results HTML file N/A  
Form 10-Q May 4, 2017 HTML file  PDF file   View XBRL 829.7 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
2016 Annual Report   PDF 871.1 KB Add to Briefcase
Form 10-K Mar 14, 2017 HTML file  PDF file   View XBRL 871.1 KB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFA14A) Jun 7, 2017 HTML file  PDF file 1.3 MB Add to Briefcase
Proxy Statement Apr 17, 2017 HTML file  PDF file 1.3 MB Add to Briefcase

Add to Briefcase = add PDF file to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
8.12
Change:
+ 0.08
Day High:
8.21
Day Low:
8.07
Volume:
696,977
4:00 PM ET on Jul 21, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR